LR Health & Beauty SE shareholder Quadriga Capital announced it has won private equity firm Evoco as a major investor in the company. This capital infusion will provide more financial backing that will allow the company to continue driving toward its strategic initiatives.
The company also successfully placed a $140 million New Bond with its institutional investors in Germany and Europe, giving the issuer of the legacy bond (LR Global Holding GmbH) proceeds of $135 million for premature refinancing.
“We are delighted that our business model and our strategy have been so well received by investors,” said Dr Andreas Laabs, CEO of LR Health & Beauty SE. “This gives us the flexibility we need to execute our business strategy. 2024 is off to a very good start and we will now focus not only on further optimizing our distribution model and launching new product innovations, but also on further digitalizing our business processes. With our new digital platform, LR neo, we have created a central information hub for our partners, which we will expand to provide them with all the information they need to pursue their business activities.”
